日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma

横纹肌肉瘤中IGFBP2表达下调与IGF1R疗法耐药相关

Kang, Z; Yu, Y; Zhu, Y J; Davis, S; Walker, R; Meltzer, P S; Helman, L J; Cao, L

Autocrine Transforming Growth Factor-beta Growth Pathway in Murine Osteosarcoma Cell Lines Associated with Inability to Affect Phosphorylation of Retinoblastoma Protein.

小鼠骨肉瘤细胞系中自分泌转化生长因子-β生长途径与无法影响视网膜母细胞瘤蛋白磷酸化有关

Navid F, Letterio J J, Yeung C L, Pegtel M, Helman L J

Molecular alterations in pediatric sarcomas: potential targets for immunotherapy

儿童肉瘤的分子改变:免疫治疗的潜在靶点

Goletz, T J; Mackall, C L; Berzofsky, J A; Helman, L J

Disruption of the MyoD/p21 Pathway in Rhabdomyosarcoma

横纹肌肉瘤中MyoD/p21通路紊乱

Weintraub, M; Kalebic, T; Helman, L J; Bhatia, K G

Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma

横纹肌肉瘤中涉及的胰岛素样生长因子II基因印记等位基因的激活

Zhan, S; Shapiro, D N; Helman, L J

Chromogranin A expression in normal and malignant human tissues

嗜铬粒蛋白A在正常和恶性人体组织中的表达

Helman, L J; Gazdar, A F; Park, J G; Cohen, P S; Cotelingam, J D; Israel, M A

Molecular markers of neuroendocrine development and evidence of environmental regulation

神经内分泌发育的分子标志物及环境调控的证据

Helman, L J; Thiele, C J; Linehan, W M; Nelkin, B D; Baylin, S B; Israel, M A